WHO Intergovernmental Working Group on public health, innovation and intellectual property.

نویسنده

  • Trevor M Jones
چکیده

The inaccessibility of medicines in lowand middle-income countries poses serious human rights and developmental challenges for Governments and international organizations, as well as raising grave ethical and human rights questions about the responsibilities of the research and development-based pharmaceutical industry. In response to this human rights and public-health dilemma, there has been growing attention to the relationship between intellectual property rights, innovation and public-health, leading to an intergovernmental process initiated and led by the World Health Organization (WHO) between 2006 and 2008. The Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (here inafter “Intergovernmental Working Group”) engaged WHO member States, non-governmental organizations (NGOs), intergovernmental organizations and the pharmaceutical industry in an 18-month process to produce a global strategy and plan of action. The object of the Global Strategy on Public Health, Innovation and Intellectual Property1 (hereinafter “Global Strategy”) and its Plan of Action2 is to “provide a medium-term framework for securing an enhanced and sustainable basis for needs-driven essential health

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property.

The appropriate role of innovation and intellectual property (IP) in global public health is a controversial issue. Discussion is one-sided, with potential benefits advocated by industry in stark contrast to condemnation by certain civil society players. WHO's Public Health, Innovation and Intellectual Property Department (PHI) was established to address healthcare resource need for developing ...

متن کامل

Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective.

The report issued by WHO’s Commission on Intellectual Property, Innovation, and Public Health1 (CIPIH) makes a number of positive recommendations for improving health in developing countries. However, the report understates the value of intellectual property rights for promoting public health and overstates the importance of intellectual property in affecting access to health care. Indeed, the ...

متن کامل

Sri Lanka's national assessment on innovation and intellectual property for access to medical products.

In 2008, the Global strategy and plan of action on public health, innovation and intellectual property (GSPA-PHI) was launched by the World Health Organization, to stimulate fresh thinking on innovation in, and access to, medicines and to build sustainable research on diseases disproportionately affecting low- and middle-income countries. As part of the activities of the GSPA-PHI, Sri Lanka has...

متن کامل

Business as Usual: A Lack of Institutional Innovation in Global Health Governance; Comment on “Global Health Governance Challenges 2016 – Are We Ready?”

There were once again high expectations that a major global health event - the Ebola virus outbreak of 2014-2015 - would trigger meaningfully World Health Organization (WHO) reform and strengthen global health governance (GHG). Rather than a “turning point,” however, the global community has gone back to business as usual. This has occurred against a backdrop of worldwide political turmoil, cha...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Lancet

دوره 376 9734  شماره 

صفحات  -

تاریخ انتشار 2010